Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects

Biological Psychiatry

Volumn 54, Issue 7, 2003, Pages 674-681

  Steffens, David C ^a   Trost, William T ^a   Payne, Martha E ^a   Hybels, Celia F ^a   MacFall, James R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein E; Depression; Elderly; Hyperintensities; Magnetic resonance imaging

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ALLELE; ARTICLE; BRAIN SCINTISCANNING; CEREBROVASCULAR DISEASE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE LOCUS; GENOTYPE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; GENETICS; GERIATRIC ASSESSMENT; HOSPITALIZATION; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL RATING SCALE; REPRODUCIBILITY; STATISTICS;

AGED; ALLELES; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; GENOTYPE; GERIATRIC ASSESSMENT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 0142040222     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01782-1     Document Type: Article

References (29)

1. Bartres-Faz D., Junque C., Clemente I.C., Serra-Grabulosa J.M., Guardia J., Lopez-Alomar A., et al. MRI and genetic correlates of cognitive function in elders with memory impairment. Neurobiol Aging. 22:2001;449-459.
2. Bronge L., Fernaeus S.E., Blomberg M., Ingelson M., Lannfelt L., Isberg B., et al. White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype. Dement Geriatr Cogn Disord. 10:1999;89-96.
3. Byrum C.E., MacFall J.R., Charles H.C., Chitilla V.R., Boyko O.B., Upchurch L., et al. Accuracy and reproductibility of brain and tissue volumes using a magnetic resonance imaging segmentation method. Psychiatry Res. 67:1996;215-234.
4. Class C.A., Unverzagt F.W., Gao S., Sahota A., Hall K.S., Hendrie H.C. The association between Apo E genotype and depressive symptoms in elderly African-American subjects. Am J Geriatr Psychiatry. 5:1997;339-343.
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
6. DeCarli C., Reed T., Miller B.L., Wolf P.A., Swan G.E., Carmelli D. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke. 30:1999;1548-1553.
7. Doody R.S., Azher S.N., Haykal H.A., Dunn J.K., Liao T., Schneider L. Does APO epsilon4 correlate with MRI changes in Alzheimer's disease? J Neurol Neurosurg Psychiatry. 69:2000;668-771.
8. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:1975;189-198.
9. Forsell Y., Corder E.H., Basun H., Lannfelt L., Viitanen M., Winblad B. Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+. Biol Psychiatry. 42:1997;898-903.
10. Grossman H.T., Jacobson S., Folstein M.F. Neuroimaging and the normal elderly. Ames D., Chui E. Neuroimaging in the Psychiatry of Late Life. 1997;Cambridge University Press, New York.
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;55-61.
12. Harris G.J., Schlaepfer T.E., Peng L.W., Lee S., Federman E.B., Pearlson G.D. Magnetic resonance imaging evaluation of the effects of ageing on grey-white ratio in the human brain. Neuropathol Appl Neurobiol. 20:1994;290-293.
13. Hirono N., Yasuda M., Tanimukai S., Kitagaki H., Mori E. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. Stroke. 31:2000;1263-1268.
14. Iidaka T., Nakajima T., Kawamoto K., Fukuda H., Suzuki Y., Maehara T., et al. Signal hyperintensities on brain magnetic resonance imaging in elderly depressed patients. Eur Neurol. 36:1996;293-299.
15. Kikinis R., Shenton M.E., Gerig G., Martin J., Anderson M., Metcalf D., et al. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. J Magn Reson Imaging. 2:1992;619-629.
16. Krishnan K.R., Tupler L.A., Ritchie J.C., McDonald W.M., Knight D.L., Nemeroff C.B., et al. Apolipoprotein E-epsilon 4 frequency in geriatric depression. Biol Psychiatry. 40:1996;69-71.
17. Krishnan K.R.R., Hays J.C., Blazer D.G. MRI defined vascular depression. Am J Psychiatry. 154:1997;497-501.
18. Landerman R., George L.K., Campbell R.T., Blazer D.G. Alternative models of the stress buffering hypothesis. Am J Community Psychol. 17:1989;626-642.
19. McCarron M.O., Delong D., Alberts M.J. APOE genotype as a risk factor for ischemic cerebrovascular disease A meta-analysis . Neurology. 53:1999;1308-1311.
20. Miller A.K., Alston R.L., Corsellis J.A. Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man Measurements with an image analyser . Neuropathol Appl Neurobiol. 6:1980;119-132.
21. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:1979;382-389.
22. Nebes R.D., Vora I.J., Meltzer C.C., Fukui M.B., Williams R.L., Kamboh M.I., et al. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. Am J Psychiatry. 158:2001;878-884.
23. Robins N., Helzer J.E., Croughan J., Ratcliff K.S. National Institute of Mental Health diagnostic interview schedule. Arch Gen Psychiatry. 38:1981;381-389.
24. Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
25. Schmand B., Hooijer C., Jonker C., Lindeboom J., Havekes L.M. Apolipoprotein E phenotype is not related to late-life depression in a population-based sample. Soc Psychiatry Psychiatr Epidemiol. 33:1998;21-26.
26. Schmidt H., Schmidt R., Fazekas F., Semmler J., Kapeller P., Reinhart B., et al. Apolipoprotein E e4 allele in the normal elderly Neuropsychologic and brain MRI correlates . Clin Genet. 50:1996;293-299.
27. Schmidt R., Schmidt H., Fazekas F., Schumacher M., Niederkorn K., Kapeller P., et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke. 28:1997;951-956.
28. Steffens D.C., Helms M.J., Krishnan K.R., Burke G.L. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke. 30:1999;2159-2166.
29. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild I., Salvesen G.S., et al. Apolipoprotein E High-avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease . Proc Natl Acad Sci U S A. 90:1993;1977-1981.